Department of Medicine, Division of Gastroenterology, University of California, San Francisco, CA, USA.
University of Washington School of Medicine, Seattle, WA, USA.
Lancet Infect Dis. 2016 Dec;16(12):1409-1422. doi: 10.1016/S1473-3099(16)30208-0. Epub 2016 Sep 5.
Advances in therapy for hepatitis B virus (HBV) and hepatitis C virus (HCV) have ushered in a new era in chronic hepatitis treatment. To maximise the effectiveness of these medicines, individuals must be engaged and retained in care. We analysed operational interventions to enhance chronic viral hepatitis testing, linkage to care, treatment uptake, adherence, and viral suppression or cure.
We did a systematic review of operational interventions, and did meta-analyses for sufficiently comparable data. We searched PubMed, Embase, WHO library, International Clinical Trials Registry Platform, PsycINFO, and CINAHL for randomised controlled trials and controlled non-randomised studies that examined operational interventions along the chronic viral hepatitis care continuum, published in English up to Dec 31, 2014. We included non-pharmaceutical intervention studies with primary or secondary outcomes of testing, linkage to care, treatment uptake, treatment adherence, treatment completion, treatment outcome, or viral endpoints. We excluded dissertations and studies of children only. Data were extracted by two independent reviewers, with disagreements resolved by a third reviewer. Studies were assessed for bias. Data from similar interventions were pooled and quality of evidence was assessed using GRADE. This study was registered in PROSPERO (42014015094).
We identified 7583 unduplicated studies, and included 56 studies that reported outcomes along the care continuum (41 for HCV and 18 for HBV). All studies except one were from high-income countries. Lay health worker HBV test promotion interventions increased HBV testing rates (relative risk [RR] 2·68, 95% CI 1·82-3·93). Clinician reminders to prompt HCV testing during clinical visits increased HCV testing rates (3·70, 1·81-7·57). Nurse-led educational interventions improved HCV treatment completion (1·14, 1·05-1·23) and cure (odds ratio [OR] 1·93, 95% CI 1·44-2·59). Coordinated mental health, substance misuse, and hepatitis treatment services increased HCV treatment uptake (OR 3·03, 1·24-7·37), adherence (RR 1·22, 1·05-1·41), and cure (RR 1·21, 1·07-1·38) compared with usual care.
Several simple, inexpensive operational interventions can substantially improve engagement and retention along the chronic viral hepatitis care continuum. Further operational research to inform scale-up of hepatitis services is needed in low-income and middle-income countries.
World Health Organization and US Fulbright Program.
乙型肝炎病毒(HBV)和丙型肝炎病毒(HCV)治疗的进展开创了慢性肝炎治疗的新时代。为了使这些药物的效果最大化,必须使个人参与并保持在护理中。我们分析了提高慢性病毒性肝炎检测、与护理联系、治疗接受、依从性以及病毒抑制或治愈的操作干预措施。
我们对操作干预措施进行了系统评价,并对足够可比的数据进行了荟萃分析。我们在 PubMed、Embase、世界卫生组织图书馆、国际临床试验注册平台、PsycINFO 和 CINAHL 中搜索了截至 2014 年 12 月 31 日发表的关于沿着慢性病毒性肝炎护理连续体的操作干预措施的随机对照试验和对照非随机研究。我们纳入了主要或次要结局为检测、与护理联系、治疗接受、治疗依从性、治疗完成、治疗结局或病毒终点的非药物干预研究。我们排除了专题论文和仅儿童的研究。两名独立审查员提取数据,意见分歧由第三名审查员解决。研究评估了偏倚。对类似干预措施的数据进行了汇总,并使用 GRADE 评估证据质量。本研究在 PROSPERO(42014015094)中进行了注册。
我们确定了 7583 篇未重复的研究,并纳入了 56 项报告沿着护理连续体结果的研究(41 项 HCV,18 项 HBV)。除一项研究外,所有研究均来自高收入国家。乙型肝炎病毒(HBV)检测促进措施中的非卫生专业人员干预增加了 HBV 检测率(相对风险[RR] 2.68,95%CI 1.82-3.93)。临床医生在就诊期间提醒进行 HCV 检测,提高了 HCV 检测率(3.70,1.81-7.57)。护士主导的教育干预措施提高了 HCV 治疗完成率(1.14,1.05-1.23)和治愈率(比值比[OR] 1.93,95%CI 1.44-2.59)。协调的心理健康、物质使用障碍和肝炎治疗服务提高了 HCV 治疗接受率(OR 3.03,1.24-7.37)、依从性(RR 1.22,1.05-1.41)和治愈率(RR 1.21,1.07-1.38)与常规护理相比。
一些简单、廉价的操作干预措施可以大大提高沿着慢性病毒性肝炎护理连续体的参与度和保留率。在低收入和中等收入国家,需要进一步的操作研究来为肝炎服务的扩大提供信息。
世界卫生组织和美国富布赖特计划。